Heart arrhythmias are a major U.S. health concern, with the potential to be
life-threatening and expensive to treat:
Arrhythmia increases
risk of death
by 2x1
33.5M people
worldwide have an arrhythmia2
Heart disease costs
$219 Billion
in u.s healthcare costs3
While mobile cardiac monitoring improves arrhythmia detection and patient outcomes,
several inefficiencies remain:
Delayed patient data
increases response time and
prevents prompt clinical
intervention.
Patient compliance is negatively impacted by multiple devices, chargers, sensors and device connections.
Lack of direct access to care, without an office visit, can unnecessarily delay treatment.
Introducing RhythmStar, the only wearable 4-in-1 cardiac monitor with built-in cellular connectivity that continuously and discreetly connects patients and clinicians for improved patient care.
CDC Heart Disease Facts - Accessed July 16, 2020